Clinical Trial Update: Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of Posiphen in subjects with early Alzheimer's disease has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• POSIPHEN (posiphen)

Snippet

Sponsor: Annovis Bio Inc. | Conditions: Alzheimer's Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-05-09